Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. - Wikidata - thesis-toulmin - TriplyDB

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

http://www.wikidata.org/entity/Q34739969

about

Collateral Damage: Detrimental Effect of Antibiotics on the Development of Protective Immune Memory A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae Considerations for the rational design of a Chlamydia vaccine Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs The Role of Non-Cognate T Cell Stimulation during Intracellular Bacterial Infection.Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.Chlamydia trachomatis control requires a vaccine.Chlamydia induces anchorage independence in 3T3 cells and detrimental cytological defects in an infection model.Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infection Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.A re-evaluation of the role of B cells in protective immunity to Chlamydia infection Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.Bioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model.VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.Increased susceptibility to Salmonella infection in signal regulatory protein α-deficient mice.Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3 Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.Animal models for studying female genital tract infection with Chlamydia trachomatis Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).Plasmid-mediated transformation tropism of chlamydial biovars.Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells.Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182 A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract.Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.Update on Chlamydia trachomatis Vaccinology.CD103+ lung dendritic cells (LDCs) induce stronger Th1/Th17 immunity to a bacterial lung infection than CD11bhi LDCs.

P2860

Q28066947-0AF9B3D7-2597-4DC4-A367-8016DC9EF27C Q28391567-56AEAC8A-C1DD-4DDC-A137-340D0C7596EE Q33570163-2A0013B2-0462-4020-A42B-14D531C7E042 Q33601324-CAB9177C-70CE-480B-8F19-17A63604F6BC Q33632705-EDCB4F25-465A-4B8A-B515-9A280537EFB3 Q33648677-6DB21320-C7CA-4007-82A1-2704516CF060 Q33740057-4E6426FB-2A59-43C2-A8DC-FBA9D4E22E93 Q33872734-DB0F9F89-E7A7-4366-B0C0-F6129582FE2D Q33957971-989D0F69-D2EF-47FD-BE53-2F5022EF2F9C Q34103774-93A35034-AC1F-4CEF-9EFF-970A51B541DE Q34545451-676D72C6-DA48-411F-A28A-658B08EE8B31 Q34680475-C2BA0A85-8AD6-4FC0-9AC7-7C7D34129789 Q35005164-2EF4C11B-8355-4B6D-ADA6-038087257296 Q35169667-D737F2B6-8282-48A3-90B1-6C0501F73027 Q35471373-01CA9F2B-02BF-49FD-9546-D62F7A5CAC9C Q35609703-54B203C7-CFB4-4898-BA03-CD87A0A506D1 Q35679647-DE799948-2F35-4838-BEA5-941B6639F35F Q35891541-800BB381-59C4-433C-BC88-6C230B467E4C Q36088710-120E7E16-643C-410D-8004-626264589B7E Q36161076-474BFA49-6650-4182-AAFE-F736266F0885 Q36179550-18CAB638-F922-430F-A0CC-E81A5F5BB499 Q36211625-3361B461-1936-4708-9A67-9921306D400E Q36585704-A38DE7E7-A6F4-4FF1-8BC0-32DDD82E1A1D Q36685400-DE8C8444-73D9-4D34-87AB-7128F669DD4C Q36950621-DD5E4F9A-A389-44EF-963E-EA2B1F629942 Q37123840-0672CAE2-0060-4799-953A-7897F618C9CF Q37159712-4E652CAC-CE22-41F9-ABC6-FAB246B38A19 Q37264979-E828A748-5D92-43C0-A0E0-D989C5DD5E54 Q37345928-4EF9F686-F29C-43A8-8079-84E4DA98BFEC Q37347397-E5B2F723-E1E1-4D47-A9D8-A3E4998C3B13 Q37624678-2A4F98D5-C0AA-491C-9BDC-287534F48314 Q37646878-D388EA50-9786-44EF-9B1A-4A2F1D20D729 Q37651368-471613E5-FCCE-445D-AB7D-96CFA8A6FE91 Q37662122-2FA63FD4-9B2C-4742-ACF0-078E9F65340D Q37662675-348898B6-7808-476E-93A5-4825F57A07F9 Q37712799-FB529640-DA67-4033-9987-CC721A627719 Q37833657-70777826-6BD4-4354-8D11-80228DCE1D32 Q37834482-115A7E19-A92D-40A0-892B-3DF0BA63E5EC Q37834874-7C9C347B-E922-4B05-9BDE-AF554E4A698E Q37834957-EDA2253B-8EDD-4D50-A854-8DA9F6AA77F4

P2860

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

http://www.wikidata.org/entity/Q34739969

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@ast

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@en

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@nl

type

label

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@ast

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@en

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@nl

prefLabel

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@ast

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@en

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@nl

P1433

Q34739969-043C9226-DDB5-471B-A4D6-A7EE8FCAFDF3

P1476

Q34739969-763150A5-F854-46AC-B385-4BD6F7F4DA35

P2093

Q34739969-B5564E01-E02F-4070-B0B8-70CCFB673005

Q34739969-C62EF4B3-BC1B-4CA3-91B4-1C994655AEE3

P2860

Q34739969-05FE32FE-F174-4DF9-BF78-D63996D655D6

Q34739969-0948A6AC-3470-47B7-96E3-5B460F95B638

Q34739969-0DB17164-C1A8-446D-BC5F-5B00AEB5FF0E

Q34739969-125071C4-B90B-42D2-B65E-CCA6D0C2312E

Q34739969-1A58BB3C-D5FB-4656-ADD5-A25CF48BE811

Q34739969-1C4EAA2F-1E4F-4445-BAE9-23573F599E98

Q34739969-1C71B546-F23E-46CC-B7C7-C016B78895B6

Q34739969-1EA1BFAB-4DA4-49F0-84AA-B5D2E2573051

Q34739969-254587FC-F0C0-4567-86BE-620F6887D9C8

Q34739969-25AFF7A1-4FE1-46FF-8239-4FABD044B877

P304

Q34739969-85F6562C-82B4-42FB-836B-7B6184864207

P31

Q34739969-52947AB7-6F98-4D2F-B27B-83A1DB1DD7AE

P356

Q34739969-1F008D19-A8D9-4696-ADB9-CC1C05DC6C79

P407

Q34739969-C5DFADB7-8CD3-4B21-BEDE-E0E7394AC3F4

P433

Q34739969-D584625B-7CC4-4E92-91CF-8BC1B62AC6FC

P478

Q34739969-8FB90860-330A-4DE2-9DA9-DABC55DFABD7

P577

Q34739969-6CF0AD5A-CC87-41A0-9037-83F0A713C4EA

P5875

Q34739969-57FD9DE1-2682-408B-9C1C-C515A6E98FE4

P698

Q34739969-946F8F57-C65A-4661-ACEF-9F0C2AAEB373

P932

Q34739969-42630D6A-DA81-439A-815A-EF698E43997D

P356

P1433

Infection and Immunity

P1476

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

@en

P2093

Christina M Farris

http://www.w3.org/2001/XMLSchema#string

Richard P Morrison

http://www.w3.org/2001/XMLSchema#string

P2860

Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis

Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Structural basis for activation and inhibition of the secreted chlamydia protease CPAF

AN UNIDENTIFIED VIRUS WHICH PRODUCES PNEUMONIA AND SYSTEMIC INFECTION IN MICE

Expression library immunization confers partial protection against Chlamydia muridarum genital infection.

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.

Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Chlamydial protease-like activity factor--insights into immunity and vaccine development

Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection

P304

986-996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00881-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47794195

http://www.w3.org/2001/XMLSchema#string

P698

21078844

http://www.w3.org/2001/XMLSchema#string

P932

3067520

http://www.w3.org/2001/XMLSchema#string